Our mission

Howard Rosen is an experienced medtech executive, with a successful 30-year track record leading business units and franchises for emerging and mature cardiovascular medical device companies. Under Mr. Rosen’s leadership, his teams developed new therapeutic medical device solutions, achieved record revenues, commercialized new products, and developed strategic partnerships.  

Most recently, Mr. Rosen served as Vice President of Marketing and Business Development at Intact Vascular and then transitioned to Head of Intact Vascular integrating the company when it was acquired by Royal Philips (NYSE: PHG), in 2020. During his time at Intact Vascular he simultaneously held the position of Vice President of Marketing and Business Development for Vesper Medical, a spinout of Intact Vascular, which was also acquired by Royal Philips in 2022. Previously, he was Vice President of the Blood Collections Business Unit at Haemonetics (NYSE: HAE) and prior to that he was Vice President of Sales and Marketing at BG Medicine, a Flagship Pioneering company. Mr. Rosen spent 21 years at Boston Scientific Corporation (NYSE: BSX), starting out early in his career as a Territory Sales Manager and advancing through the Marketing ranks to hold positions of increasing responsibility in the peripheral vascular interventions and cardiovascular business units. Mr. Rosen earned a B.S. in Business Administration from Northeastern University.

Danielo Piazza has more than 25 years of experience leading the design and development of software driven diagnostics and therapy delivery systems from concept through product launch for medical device companies, including 15 years developing catheter-based, image-guided diagnostic and therapy systems.

Most recently, he was Chief Engineer at Auris Health Inc. (acquired by Johnson & Johnson in 2019), where he helped to develop and expand indications for the Monarch flexible robotics platform. Prior to that, he was Vice President of Software Engineering at VytronUS, where he authored numerous patents for the ultrasound based robotically controlled, 3D image-guided therapy planning and ablation platform. While at Hansen Medical, he led the Systems and Software Engineering teams for both Sensei and Magellan robotic platforms. He led multiple new product development efforts while at Carl Zeiss Meditec for OCT imaging based automated diagnostic measurement systems, and previously, helped to develop state of the art ultrasound transducers for Acuson (acquired by Siemens Ultrasound in 2000). 

Mr. Piazza holds a Masters in Software Engineering from Santa Clara University and a Bachelor of Science degree in Electronic Engineering from California Polytechnic State University, San Luis Obispo.

Patrick Phillips, Ph.D., is a seasoned executive and technical leader with over 27 years experience developing medical products including robotic platforms for imaging diagnostics and therapy, minimally invasive imaging, catheter-based cardiovascular devices, and premium diagnostic ultrasound systems. He holds 36 medical device patents.

Most recently, as Vice President of R&D at J&J Ethicon, he led innovation for their robotics digital surgery platforms. Prior to the acquisition by J&J in 2019 of VytronUS, Inc., he served as Senior Vice President, Engineering and Manufacturing and held other engineering positions while leading the development of a novel ultrasound-based robotic 3D navigation system for imaging and treatment of cardiac arrhythmias. Before the acquisition of Fluid Medical by Volcano/Philips in 2010, he was Director of Engineering and led early-stage device and system development for intravascular imaging. Prior to Fluid Medical, Dr. Phillips held the positions of Technical Fellow and Sr. Engineering Manager at Acuson, later acquired by Siemens Medical Solutions, where he developed and invented novel solutions for high-end ultrasound systems.

He holds a Doctor of Philosophy in Biomedical Engineering from Duke University and a Bachelor of Science in Electrical and Computer Engineering from Clarkson University.